Promoter Methylated Tumor Suppressor Genes in Glioma
Authors:
- 1 January 2015
- journal article
- review article
- Published by Medknow in Cancer Translational Medicine
- Vol. 1 (4) , 123
Abstract
Epigenetic silencing of tumor suppressor genes (TSGs) is critical for glioma initiation and progression. Emerging reports suggest that increased numbers of TSGs, which are critical to cell cycle, proliferation, apoptosis, migration, invasion, DNA repair, and signaling pathways, were silenced in gliomas. Tumor-specific methylation of TSGs in glioma indicates that they could be used as epigenetic biomarkers for molecular diagnosis and therapeutics. This review summarizes the recent discoveries of epigenetically silenced TSGs in human gliomas, providing better understanding of disrupted epigenetic regulation in glioma progression.Keywords
This publication has 12 references indexed in Scilit:
- CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade gliomaTumor Biology, 2015
- Prognostic prediction of glioblastoma by quantitative assessment of the methylation status of the entire MGMT promoter regionBMC Cancer, 2014
- Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiformeCancer Gene Therapy, 2014
- Opposing Effects of PI3K/Akt and Smad-Dependent Signaling Pathways in NAG-1-Induced Glioblastoma Cell ApoptosisPLOS ONE, 2014
- The role of theTP73gene and its transcripts in neuro-oncologyBritish Journal Of Neurosurgery, 2014
- Down-Regulation of Neogenin Accelerated Glioma Progression through Promoter Methylation and Its Overexpression in SHG-44 Induced ApoptosisPLOS ONE, 2012
- Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human gliomaJournal of Translational Medicine, 2011
- Epigenomic Profiling Reveals Novel and Frequent Targets of Aberrant DNA Methylation-Mediated Silencing in Malignant GliomaCancer Research, 2006
- MOLECULAR PATHOLOGY OF MALIGNANT GLIOMASAnnual Review of Pathology: Mechanisms of Disease, 2006
- Stat3 as an OncogeneCell, 1999